Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.

Human brains are wired to hold on to fat, resist calorie restriction, and push themselves towards foods that keep them alive, even if they make them gain weight in modern life ...

Looking for your next favorite read? Here's your sign to dive into stories that inspire, heal, and make you think. From ...

Just as U.S. households were fretting about the effect on travel and the wider economy of the longest-ever government shutdown, the U.S. Senate on Sunday finally began the process of re-opening ...

Late Friday, after a dramatic bidding war, he learned he’d finally claimed his prize. Bourla found out at around 9 p.m. that ...

Eli Lilly and Novo Nordisk’s competition in weight-loss drugs has affected thousands of jobs between Charlotte and Raleigh.

While this coincides with an uptick in GLP-1 drug use, some experts told Newsweek they don't think they are having a major ...

(Reuters) -Metsera shareholders on Thursday approved Pfizer's takeover offer worth up to $10 billion, allowing the U.S.

The US FDA is removing serious health warnings from hormone replacement therapies. Scientists worry that more work is needed ...

Having stable access to nutritious food sets children up for better mental and physical health into adulthood.

The question now is how to best serve the millions who, freed from a lifetime of yo-yo dieting, are re-engaging with their ...